Anteris Technologies Gears Up for Major Healthcare Events

Anteris Technologies Gears Up for Major Healthcare Events
MINNEAPOLIS and BRISBANE, Australia — Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is excited to announce that its Chief Executive Officer, Wayne Paterson, will be presenting at two significant healthcare conferences: the TD Cowen 45th Annual Healthcare Conference and the Barclays 27th Annual Global Healthcare Conference. With a commitment to innovation in structural heart technology, Anteris aims to showcase its cutting-edge DurAVR THV, a first-in-class balloon-expandable heart valve designed to restore healthy heart function.
Conference Participation Details
Wayne Paterson will be part of various events at these esteemed conferences, presenting the company's advancements and vision for the future. Below, we summarize the details of each session:
TD Cowen 45th Annual Healthcare Conference
Date: Wednesday, March 5, 2025 (US time)
Format: Fireside chat with analyst, Joshua Jennings, followed by one-on-one meetings
Time: 9:10 AM - 9:40 AM (US EST)
Room: Provincetown, 4th Floor
Location: Marriott Copley Plaza, Boston, MA
Additionally, Anteris’ Chief Medical Officer, Dr. Chris Meduri, will participate as an expert panelist in a discussion focusing on Structural Heart - TAVR.
Barclays 27th Annual Global Healthcare Conference
Date: Tuesday, March 11, 2025 (US time)
Format: Fireside chat with analyst, Matt Miksic, followed by one-on-one meetings
Time: 9:00 AM - 9:25 AM (US EST)
Room: Americana 3 (Track 3)
Location: Loews Miami Beach, Miami, FL
Webcast Access
The webcasts for the TD Cowen and Barclays conferences will be available for those who wish to follow along. Interested parties can access the presentations through the Investor Center section on Anteris’s official website, where replays will also be available to view for up to 90 days.
About Anteris Technologies
Founded in Australia and with a robust presence in Minneapolis, USA, Anteris Technologies (NASDAQ: AVR, ASX: AVR) is dedicated to creating innovative medical devices that address structural heart conditions. The company's lead product, the DurAVR Transcatheter Heart Valve, is a remarkable achievement in cardiac technology. Developed with insights from top interventional cardiologists and surgeons, the DurAVR valve addresses aortic stenosis by mimicking the functionality of a healthy aortic valve. This biomimetic design is made from Anteris's proprietary ADAPT technology, which has proven effective in over 55,000 patients worldwide.
Anteris continues to drive innovation in the field of cardiology and remain committed to improving patient outcomes through their advanced medical solutions.
Frequently Asked Questions
What is Anteris Technologies known for?
Anteris Technologies is recognized for its innovative heart valve technologies, particularly the DurAVR THV, which aims to restore heart function in patients with aortic stenosis.
Who will present at the upcoming healthcare conferences?
Wayne Paterson, the CEO of Anteris Technologies, along with Dr. Chris Meduri, the Chief Medical Officer, will be presenting and participating in discussions at the conferences.
When is the TD Cowen Conference?
The TD Cowen Conference will take place on Wednesday, March 5, 2025, with Wayne Paterson presenting at 9:10 AM (US EST).
How can I access the conference presentations?
Webcasts for the presentations will be available on the Investor Center section of Anteris's website, allowing viewers to follow the discussions and access replays for 90 days.
What is the significance of the DurAVR heart valve?
The DurAVR heart valve is significant as it represents advancement in heart valve technology, designed to mimic healthy valve function and improve patient outcomes for those suffering from aortic stenosis.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.